Medicine information DESFERAL 500mg powder for solution for injection / infusion

Product code:: W71452001
Quantity:: 10
Indicated for:: iron overload
Route of administration:: injectable / infusion
Substance:: deferoxamine (chelating agent)
ATC: V03AC01 — Various | All other therapeutic products | All other therapeutic products | Iron chelating agents

Deferoxamine is a medication used for the treatment of iron overload, a condition that can occur after repeated blood transfusions, such as in thalassemia or other hematological disorders. It acts as a chelating agent, binding to excess iron and facilitating its elimination through urine or feces.

The medication is administered as subcutaneous or intravenous injections, usually over the long term. It is effective in preventing complications associated with iron overload, such as organ damage.

Side effects may include injection site reactions, nausea, vomiting, diarrhea, and, in rare cases, hearing or vision loss. Regular monitoring of iron levels and organ function is essential.

Consult your doctor to discuss the benefits and risks of treatment with Deferoxamine. Follow all medical recommendations to ensure treatment effectiveness.

General data about DESFERAL 500mg

Substance:: deferoxamine
Date of latest medicines list:: 01-10-2026
Product code:: W71452001
Strength:: 500mg
Pharmaceutical form:: powder for solution for injection / infusion
Quantity:: 10
Product type:: Original
Price:: 149.09 RON
Prescription status:: P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:: NOVARTIS PHARMA GMBH - GERMANIA
Holder:: MITEM PHARMA - FRANTA
Number:: 9446/2016/01
Shelf life:: 3 years-after packaging for sale;after reconstitution-use immediately

Official documents

Professional information (SmPC) - Romanian Patient leaflet - Romanian Packaging and labelling information - Romanian

The correspondence between the document and the displayed text is unconfirmed.

Source institution: ANMDMR
Document language: Romanian

Reimbursement lists for DESFERAL 500mg Mitem Pharma

G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors

Price: 149.09 RON
Copayment: 149.09 RON
Patient payment: 0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price: 149.09 RON
Copayment: 149.09 RON
Patient payment: 0.00 RON

NHP 6.1 (C2) - Hemophilia and thalassemia

Price: 149.09 RON
Copayment: 149.09 RON
Patient payment: 0.00 RON